PATENT CLAIM ANALYSIS

Application Number: 16079589
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "489000"]

Abstract:
The present invention provides a pharmaceutical composition containing a pyrrolo-fused six-membered heterocyclic compound or a pharmaceutically acceptable salt of the compound. Specifically, the invention provides a pharmaceutical composition containing 5-(2-diethylamino-ethyl)-2-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidene-methyl)-3-methyl-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one or a pharmaceutically acceptable salt thereof, and at least one water soluble filler. The pharmaceutical composition of the invention features a rapid dissolution and good stability.

Claim (Index 8):
The pharmaceutical composition according to  claim 1 , further comprising a lubricant, wherein the lubricant is at least one selected from the group consisting of talc, magnesium stearate, zinc stearate, sodium stearyl fumarate, glyceryl behenate, sodium lauryl sulfate, hydrogenated vegetable oil and colloidal silicon dioxide.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.62222
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16077610', '13142116', '16343171', '12993629', '13703120']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7347750053438081
- 35 USC 102 Novelty (BERT): 0.4976689180617232
- Combined Prediction Score: 0.7110643966155996
- Mean Citation Score: 257.427704
- Max Citation Score: 281.33914
- Similarity Product: 243.2782023918438

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test